1. Show article details.

    Coca-Cola Science and Health Officer Applebaum Retires

    DJ Business News – 8:15 PM ET 11/24/2015

    A Coca-Cola Co. (KO) executive overseeing health research is stepping down after the soda giant came under fire for funding researchers accused of downplaying the role of sugary drinks in obesity. Atlanta-based Coke said Tuesday that Chief Science and Health Officer Rhona Applebaum, 61, had decided to retire. A spokeswoman added there are no immediate plans to fill the position.

  2. Show article details.

    Exxon Gets Subpoena From N.Y. Regarding Climate-Change Research

    DJ Business News – 5:45 PM ET 11/05/2015

    Exxon Mobil Corp. (XOM) has received a subpoena from the New York attorney general's office seeking information about the company's research on and response to climate change over several decades, the company said Thursday. The investigation was confirmed by New York Attorney General Eric Schneiderman's office, which declined further comment. The probe is focused on potential consumer and securities fraud stemming from Exxon's public statements on global warming.

  3. Show article details.

    PRESS DIGEST - Hong Kong - Nov 5

    Reuters – 8:58 PM ET 11/04/2015

    These are some of the leading stories in Hong Kong newspapers on Thursday. SOUTH CHINA MORNING POST. - Commercial Radio has decided not to object to the gag order sought by the University of Hong Kong to ban media publication of information about its council meetings, two sources said.

  4. Show article details.

    Amazon Adds Paternity Leave, More Paid Time Off for Mothers

    DJ Business News – 5:55 PM ET 11/02/2015

    Amazon.com Inc. (AMZN) is delivering a long-awaited benefit for new fathers: paternity leave. Under the e-commerce giant's revised family-leave policy, new birth or adoptive parents, regardless of gender, who have worked for the company for at least a year will get six weeks of paid parental leave, marking the first time Amazon (AMZN) has offered paid time off for fathers. With the policy change, announced to employees on Monday, Amazon (AMZN) joins a slew of companies in technology and other...

  5. Show article details.

    New York Times Publisher Announces Plans for His Successor

    DJ Business News – 2:35 PM ET 11/02/2015

    The New York Times Co. (NYT) will choose a successor to publisher Arthur Sulzberger within the next two years, he said during a speech to employees on Monday. Sulzberger said the company has begun a process to select a deputy publisher, who would be in line to take his place. "I've been in my role as publisher for more than 20 years and I've hit my mid-60s, so it should come as no surprise that the task of choosing my successor has begun," the 64- year-old Mr.

  6. Show article details.

    NYT sees big digital revenue gains from outside U.S. by 2020

    Reuters – 5:29 PM ET 10/29/2015

    New York Times Co (NYT) reported a higher-than-expected quarterly profit, and said it expected digital revenue from its international business to account for a significant portion of its revenue in five years. The newspaper publisher said earlier this month that it aimed to double its annual digital revenue to $800 million by 2020 with a focus on winning over smartphone users.

  7. Show article details.

    NYT sees big part of digital revenue from outside U.S. by 2020

    Reuters – 3:28 PM ET 10/29/2015

    New York Times Co (NYT) said it expected a "significant part" of its targeted $800 million annual digital revenue by 2020 to come from outside the United States.

  8. Show article details.

    New York Times Swings to Profit

    DJ Business News – 10:05 AM ET 10/29/2015

    New York Times Co. (NYT) swung to a third-quarter profit on strong digital subscription growth, improvement in print advertising trends and lower expenses. Chief Executive Mark Thompson touted the latest period as the Times' "best advertising quarter of the year." That was despite uncharacteristic weakness in digital ad revenue, which fell 5% in the period, the first decline in more than a year.

  9. Show article details.

    New York Times reports better-than-expected profit

    Reuters – 8:46 AM ET 10/29/2015

    New York Times Co (NYT) reported a higher-than-expected quarterly profit as its cost-cutting initiatives paid off. Net income attributable to shareholders from continuing operations was $9.4 million, or 6 cents per share, in the third quarter, compared with a loss of $12.5 million, or 8 cents per share, a year earlier.

  10. Show article details.

    New York Times beats profit and revenue estimates

    MarketWatch – 8:43 AM ET 10/29/2015

    New York Times Co. (NYT) said Thursday it had net income of $9.4 million, or 6 cents a share, in the third quarter, after a loss of $12.5 million, or 8 cents a share, in the year-earlier period. Adjusted per-share earnings came to 9 cents, ahead of the FactSet consensus of 6 cents. Revenue rose to $367 million from $365 million, also ahead of the FactSet consensus of $365 million.

  11. New York Times sees ad revenue up in mid-single digits in Q4

    MarketWatch – 8:36 AM ET 10/29/2015
  12. New York Times adds 51K digital subscribers in Q3

    MarketWatch – 8:36 AM ET 10/29/2015
  13. New York Times Q3 revenue $367 mln vs $374 mln; FactSet consensus $365 mln

    MarketWatch – 8:35 AM ET 10/29/2015
  14. New York Times Q3 adj EPS 9 cents; FactSet consensus 6 cents

    MarketWatch – 8:35 AM ET 10/29/2015
  15. New York Times Q3 EPS 6 cents vs loss 8 cents

    MarketWatch – 8:34 AM ET 10/29/2015
  16. Show article details.

    The New York Times Company Reports 2015 Third-Quarter Results

    Business Wire – 8:30 AM ET 10/29/2015

    The New York Times Company (NYT) announced today adjusted diluted earnings per share from continuing operations of $.09 in the third quarter of 2015 compared with $.03 in the third quarter of 2014. Adjusted operating profit grew to $47.6 million in the third quarter of 2015 from $40.0 million in the third quarter of 2014. “This was a strong quarter for The New York Times Company.

  17. Show article details.

    The New York Times Company Names Nick Rockwell Chief Technology Officer

    Business Wire – 2:15 PM ET 10/27/2015

    The New York Times Company (NYT) today announced that Nick Rockwell has been named chief technology officer, effective November 16. “Nick combines a deep understanding of technology with real insight into the challenges of the digital media business,” Mr. Wilson said.

  18. Show article details.

    Goldman in Talks on $50 Million Fine Over Release of N.Y. Fed Secrets

    DJ Business News – 11:15 PM ET 10/26/2015

    A state banking regulator is poised to fine Goldman Sachs Group Inc. (GS) $50 million for a former employee's alleged obtaining and sharing of confidential supervisory materials from the Federal Reserve Bank of New York, according to people familiar with the matter. The New York Department of Financial Services is putting the finishing touches to a tentative agreement with Goldman to resolve the matter, the people said, noting the language may yet change. The terms of an agreement...

  19. Show article details.

    Valeant Rebuts Critical Report That Pummels Stock

    DJ Business News – 3:05 PM ET 10/21/2015

    In a chaotic day of trading, once-highflying Valeant Pharmaceuticals International Inc. (VRX) defended itself Wednesday against some of the most severe criticism yet of its business practices, denying allegations of improper accounting from an investor who is betting against the company. The short-seller's report knocked Valeant's stock down 40%- wiping some $20 billion from its market value-before the stock made up some of the loss after analysts expressed support and...

  20. Show article details.

    Drug Makers Respond to Concerns Over Specialty-Pharmacy Use

    DJ Business News – 2:05 PM ET 10/21/2015

    Allergan PLC (AGN) and Endo International PLC (ENDP) on Wednesday moved to allay concerns about their usage of specialty pharmacies, as questions swirl about some drug makers' relationships with pharmacies that distribute their drugs. The statements came after a report from short-selling research firm Citron Research raised questions about Valeant Pharmaceuticals International Inc.' s relationship with a specialty pharmacy known as Philidor. Allergan (AGN) said it has no ownership or...


Today's and Upcoming Events

  • Feb

    NYT to announce Q4 earnings Before Market (Unconfirmed)

Past Events (last 90 days)

  • Oct

    NYT Earnings Conference Call at 11:00 AM Listen

  • Oct

    NYT ex-Dividend for $0.04 on 10/5/2015

    • Announce Date: 9/17/2015
    • Record Date: 10/7/2015
    • Pay Date: 10/22/2015
Data provided by Wall Street Horizon, Inc. © 2015

Technical Events

Technical Analysis

As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.

Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.